Document Detail


Early mortality and cause of deaths in patients using HAART in Brazil and the United States.
MedLine Citation:
PMID:  19770698     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To compare the early mortality pattern and causes of death among patients starting HAART in Brazil and the United States.
METHODS: We analyzed the combined data from two clinical cohorts followed at the Johns Hopkins AIDS Service in Baltimore, United States, and the Evandro Chagas Clinical Research Institute AIDS Clinic in Rio de Janeiro, Brazil. Participants included those who entered either cohort between 1999 and 2007 and were antiretroviral naive. Follow-up was at 1 year since HAART initiation. Cox proportional hazards regression analysis was used to assess the role of the city on the risk of death.
RESULTS: A total of 859 and 915 participants from Baltimore and Rio de Janeiro, respectively, were included. In Rio de Janeiro, 64.7% of deaths occurred within 90 days of HAART initiation; in Baltimore, 48.9% occurred between 180 and 365 days. AIDS-defining illness (61.8%) and non-AIDS-defining illness (55.6%) predominated as causes of death in Rio de Janeiro and Baltimore, respectively. Risk of death was similar in both cities (hazard ratio 1.04; P value = 0.95) after adjusting for CD4 T cell count, age, sex, HIV risk group, prior AIDS-defining illness, and Pneumocystis jirovecii pneumonia and Mycobacterium avium prophylaxis. Individuals with CD4 T cell count less than or equal to 50 cells/microl (hazard ratio 4.36; P = 0.001) or older (hazard ratio, 1.03; P = 0.03) were more likely to die.
CONCLUSION: Although late HIV diagnosis is a problem both in developed and developing countries, differences in the timing and causes of deaths clearly indicate that, besides interventions for early HIV diagnosis, different strategies to curb early mortality need to be tailored in each country.
Authors:
Beatriz Grinsztejn; Valdilea G Veloso; Ruth K Friedman; Ronaldo I Moreira; Paula M Luz; Dayse P Campos; José H Pilotto; Sandra W Cardoso; Jeanne C Keruly; Richard D Moore
Related Documents :
6039368 - Intercellular communication and tissue growth. ii. tissue regeneration.
21134908 - The impact of media reporting of suicide on actual suicides in taiwan, 2002-05.
8147578 - The cayapa indians of ecuador: a population study of seven protein genetic polymorphisms.
17153268 - On teaching biopolicy and values in selected reproductive technologies: abortion, in vi...
287318 - Binaural hearing spectacles with "no mould" by acoustic trauma.
17402088 - 6-o-beta-glucopyranosylaucubin, a new iridoid from odontites verna*.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  AIDS (London, England)     Volume:  23     ISSN:  1473-5571     ISO Abbreviation:  AIDS     Publication Date:  2009 Oct 
Date Detail:
Created Date:  2009-10-13     Completed Date:  2011-01-31     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8710219     Medline TA:  AIDS     Country:  England    
Other Details:
Languages:  eng     Pagination:  2107-14     Citation Subset:  IM; X    
Affiliation:
Instituto de Pesquisa Clínica Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil. beatriz.grinsztejn@ipec.fiocruz.br
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antiretroviral Therapy, Highly Active / mortality*
Brazil / epidemiology
CD4 Lymphocyte Count
CD4-Positive T-Lymphocytes / immunology
Cause of Death
Cohort Studies
Female
HIV Infections / drug therapy,  immunology,  mortality*
Humans
Male
Middle Aged
Survival Rate
United States / epidemiology
Viral Load
Grant Support
ID/Acronym/Agency:
K24 DA00432/DA/NIDA NIH HHS; R01 AA18693/AA/NIAAA NIH HHS; R01 DA11602/DA/NIDA NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Interleukin-10 responses to therapeutic vaccination during highly active antiretroviral therapy and ...
Next Document:  Bilateral Expanded Cervico-Pectoral "Super-Thin Flap" for Entire Neck Reconstruction.